Compass Pathways Plc (CMPS)
9.21
-0.55
(-5.64%)
USD |
NASDAQ |
May 07, 12:53
Compass Pathways SG&A Expense (TTM) : 60.72M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Definium Therapeutics, Inc. | 48.64M |
| GH Research Plc | 21.95M |
| Atai Beckley, Inc. | 65.09M |
| Nektar Therapeutics | 68.67M |
| Silence Therapeutics Plc | 22.34M |